MICHAEL CAROZZA

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

S. 525, S. 1232, and H.R. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease (PAD) to Address the High Mortality Rate of this Treatable Disease - Lobbied for passage of bill. NO BILL, Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drugs Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the nee Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

S. 525, S. 1232, and H.R. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease (PAD) to Address the High Mortality Rate of this Treatable Disease - Lobbied for passage of bill. NO BILL, Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drugs Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the nee Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

S. 525, S. 1232, and H.R. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease (PAD) to Address the High Mortality Rate of this Treatable Disease - Lobbied for passage of bill. NO BILL, Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drugs Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the nee Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

S. 525, S. 1232, and H.R. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease (PAD) to Address the High Mortality Rate of this Treatable Disease - Lobbied for passage of bill. NO BILL, Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drugs Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the nee Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 3962 (House) and H.R. 3590 (Senate) - Health Care Reform - Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 & 1427/S. 726 - Biologics Price Competition & Innovation Act - Lobbied in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 - Lobbied to improve the health care system, increase access to prescription drugs, and preserve incentives to foster biopharmaceutical innovation. H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for increased education and treatment of viral hepatitis. No Bill - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions. NO BILL, Tax Reform - Lobbied to gather information on potential legislation regarding deferral of foreign income.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions. NO BILL, Tax Reform - Lobbied to gather information on potential legislation regarding deferral of foreign income.

H.R. 4213 - Tax Extenders Act - Lobbied to extend the R&D tax credit and other favorable tax provisions. No Bill - Tax Reform - Lobbied to gather information on potential legislation regarding deferral of foreign income.

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 85, S. Con. Res. 13, House and Senate Budget Resolutions. Lobbied to ensure safety and access to prescription drugs. H.R. 3326 (Defense Appropriations Act)/H.R. 3288 (Transportation/HUD Consolidated Appropriations Act)/H.J. Res. 64 (Continuing Resolution). Lobbied to ensure safety and access to prescription drugs.

H.Con.Res 85, S.Con.Res 13, House and Senate Budget Resolutions. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.Con.Res 85, Function 150, House and Senate Budget Resolutions. Lobbied Members of Congress to keep the current International Affairs FY 2010 Budget.

H.Con.Res 85, S.Con.Res 13, House and Senate Budget Resolutions. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.Con.Res 85, Function 150, House and Senate Budget Resolutions. Lobbied Members of Congress to keep the current International Affairs FY2010 Budget.

H.Con.Res 85, S.Con.Res 13, House and Senate Budget Resolutions. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 85, S. Con. Res. 13, House and Senate Budget Resolutions. Lobbied to ensure safety and access to prescription drugs. H.R. 3326 (Defense Appropriations Act)/H.R. 3288 (Transportation/HUD Consolidated Appropriations Act)/H.J. Res. 64 (Continuing Resolution). Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 85, S. Con. Res. 13, House and Senate Budget Resolutions. Lobbied to ensure safety and access to prescription drugs. H.R. 3326 (Defense Appropriations Act)/H.R. 3288 (Transportation/HUD Consolidated Appropriations Act)/H.J. Res. 64 (Continuing Resolution). Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 85, S. Con. Res. 13, House and Senate Budget Resolutions. Lobbied to ensure safety and access to prescription drugs. H.R. 3326 (Defense Appropriations Act)/H.R. 3288 (Transportation/HUD Consolidated Appropriations Act)/H.J. Res. 64 (Continuing Resolution). Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.